The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing ...

Isabella Strahan shared what she would have done differently during her brain cancer treatment eight months after announcing she was cancer-free.

First-in-human global studies initiated for ZW191, an antibody-drug conjugate (ADC) engineered to target folate receptor-⍺ ...

DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...

Some of the appeal of an Oura Rings is its ability to reveal truths about the health and fitness of its wearers.

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of ...

Jaxon Kenkel is a happy-go-lucky, 5-year-old boy, your typical baseball and hockey-loving youngster. He doesn’t know he has ...

Promising multiple dose PK data continue to support 4-weekly dosingFDA advice received supporting phase 2 design in HSStrong Key Opinion Leader (KOL) support for CAN10 in ...

PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* has reported exceptional clinical study outcomes for its HYLA blood sensor, with 96% ...

FDA designations and new study publications Recent developments include Phase 2 DMD Study Breakthrough Results ...